Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression-Reference-Cited by-同舟云学术

Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression

Published:2018-02-01 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Parada Carolina Angelica,Osbun Joshua,Kaur Sumanpreet,Yakkioui Youssef,Shi Min,Pan Catherine,Busald Tina,Karasozen Yigit,Gonzalez-Cuyar Luis Francisco^ORCID,Rostomily Robert,Zhang Jing,Ferreira Manuel

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-19308-y.pdf

Reference63 articles.

1. Wiemels, J., Wrensch, M. & Claus, E. B. Epidemiology and etiology of meningioma. J. Neuro-Oncol. 99, 307–314 (2010).

2. Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 131, 803–20 (2016).

3. Pearson, B. E. et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg. Focus. 24, E3 (2008).

4. Zang, K. D. & Singer, H. Chromosomal consitution of meningiomas. Nature. 216, 84–85 (1967).

5. Dumanski, J. P., Carlbom, E., Collins, V. P. & Nordenskjold, M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. P. Natl. Acad. Sci. USA 84, 9275–9279 (1987).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic reactivation of a neurodevelopmental phosphoprotein program in pituitary adenomas;2024-08-14

2. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis;PLOS ONE;2024-05-17

3. Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients;Neuro-Oncology;2024-05-02

4. Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma;Molecular Therapy: Oncology;2024-03

5. Impact of molecular genetic profle of meningiomas on the clinical course and recurrence using combined modality treatment;Siberian journal of oncology;2024-01-03